Showing results (211-220 of 329) with videos related to
Sort By:
Pageof 33
Occupational Medicine (Oxford, England)|January 1, 1997
Occupational medicine in Canada in 1996T L Guidotti, A Cecutti, B Gascon, et al.Scanning|March 11, 2008
Decoupling functionalization from sensor array assembly using detachable cantileversKevin W McBride, David E Snow, Stephanie Walters, et al.Infection and Immunity|January 20, 2000
Expression of the Helicobacter pylori ureI gene is required for acidic pH activation of cytoplasmic ureaseD R Scott, E A Marcus, D L Weeks, et al.Physiological Reviews|January 20, 2018
Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging ConceptsBianca C Bernardo, Jenny Y Y Ooi, Kate L Weeks, et al.Inorganic Chemistry|November 24, 2004
Synthesis and characterization of a chromium(V) cis-dioxo bis(1,10-phenanthroline) complex and crystal and molecular structures of its chromium(III) precursorColin L Weeks, Aviva Levina, Carolyn T Dillon, et al.Pain Medicine (Malden, Mass.)|May 24, 2019
Effect of Preoperative Opioid Use on Adverse Outcomes, Medical Spending, and Persistent Opioid Use Following Elective Total Joint Arthroplasty in the United States: A Large Retrospective Cohort Study of Administrative Claims DataMeridith Blevins Peratikos, Hannah L Weeks, Andrew J B Pisansky, et al.Advances in Experimental Medicine and Biology|November 4, 2017
The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and ProtectionKate L Weeks, Bianca C Bernardo, Jenny Y Y Ooi, et al.Frontiers in Physiology|July 18, 2022
New Perspectives on Sex Steroid and Mineralocorticoid Receptor Signaling in Cardiac Ischemic InjuryLaura A Bienvenu, James R Bell, Kate L Weeks, et al.The Senior Care Pharmacist|June 6, 2019
Potential Adverse Drug Events and Associated Costs During Transition from Hospital to HomeJoshua J Neumiller, Bidisha Mandal, Douglas L Weeks, et al.International Journal of Impotence Research|November 13, 2004
High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patientsJ L Weeks, R Zoraghi, A Beasley, et al.Pageof 33